Zurueck zur Suche

Reporte zur Charge U7666AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

17Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 3 MN 2 FL 2 CO 2 NE 1 MA 1 NV 1 AR 1 OR 1 MI 1 WI 1

VAERS 2660576

SANOFI PASTEUR · TDAP (ADACEL) · Charge u7666aa

kritisch
Staat
-
Alter
87,0
Geschlecht
M
Eingang
25.07.2023
Impfdatum
24.05.2023
Beginn
24.07.2023
Tage bis Beginn
61,0
Dosis
N/A
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Activated partial thromboplastin time normal Alanine aminotransferase normal Angiogram cerebral abnormal Anion gap Aphasia Aspartate aminotransferase normal Atrial fibrillation Bacterial test positive Basophil count decreased Basophil percentage Benign prostatic hyperplasia Bilirubin urine Blood albumin normal Blood alkaline phosphatase normal Blood bilirubin increased Blood calcium decreased Blood chloride increased Blood creatinine increased

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: on July 24, 2023 17:57 Verified By: on July 24, 2023 17:57 Encounter Info: Inpatient, 07/24/23 - * Final Report * History of Present Illness/Subjective Patient is a 87 year old male, hx of a-fib, HTN, CVA, MI, CAD, peripheral vascular disease, who presents to the ED via private vehicle with confusion, difficulty word-finding, and repetitive nonsensical speech onset 3 days ago. The patient's significant other at bedside reports that these symptoms onset suddenly 3 days ago. While obtaining history, the patient does not have any of these symptoms and is A&Ox4. The patient has been experiencing difficulty with ambulation secondary to complaint of fatigue, unclear exact onset. Denies any focal weakness, headache, neck pain, chest pain, abdominal pain, or other complaints. Denies hx of DM. The patient is established with primary care. Denies any pertinent PSHx. NKDA. Social history negative for tobacco use and current alcohol use. ???Upon ED evaluation imaging as below. His initial heart rate was 39, respiratory rate is 20, blood pressure was 192/59, ED EKG showed A-fib with slow ventricular response and left bundle branch block. Lab work revealed a normal white blood cell count of 5.5, hemoglobin was 10.6, potassium was 3.3, GFR was 21 which appears to be his baseline, troponin was 37 with repeat being the same. Lactate was 2.1 with repeat being 1.3. UA showed positive nitrates large leukocyte Estrace and 51-100 WBCs. COVID-19 testing was negative. Urology was consulted recommended admission here continuation of stroke work-up. ???????Patient will be admitted for further evaluation management of acute CVA, bradycardia and hypertension MRI Brain W/O IV Contrast 07/24/23 14:59:44 IMPRESSION: 1. Acute left MCA territory infarct involving predominantly the cortex of the inferior division without associated hemorrhage or significant mass effect. 2. Old left parieto-occipital infarct. 3. Technically degraded MRA, limiting evaluation. 4. Lack of flow-related signal in the left PCA, which may reflect chronic occlusion. 5. Suspected high-grade stenosis of the right P1-P2 junction. 6. Likely moderate stenoses of the left M1 segment. 7. Slight prominence of the basilar tip, nonspecific but possibly representing an aneurysm. 8. Further characterization of the above findings with CTA of the head is advised. Findings to be communicated to the ordering provider by clerical. Thank you for consulting our team of subspecialty radiologists Electronically Signed by: ************************************************** CT Head W/o IV Contrast 07/24/23 15:16:01 IMPRESSION: 1. The acute left MCA territory infarct is better depicted on MRI. 2. No acute intracranial hemorrhage or significant mass effect. Thank you for consulting our team of subspecialty radiologists. Electronically Signed by: ************************************************** XR Chest PA or AP Portable 07/24/23 13:03:49 IMPRESSION: 1. No acute findings in the chest. Thank you for consulting our team of subspecialty radiologists. Electronically Signed by: ************************************************** MRA Brain W/O IV Contrast 07/24/23 14:59:44 IMPRESSION: 1. Acute left MCA territory infarct involving predominantly the cortex of the inferior division without associated hemorrhage or significant mass effect. 2. Old left parieto-occipital infarct. 3. Technically degraded MRA, limiting evaluation. 4. Lack of flow-related signal in the left PCA, which may reflect chronic occlusion. 5. Suspected high-grade stenosis of the right P1-P2 junction. 6. Likely moderate stenoses of the left M1 segment. 7. Slight prominence of the basilar tip, nonspecific but possibly representing an aneurysm. 8. Further characterization of the above findings with CTA of the head is advised. Findings to be communicated to the ordering provider by clerical. Thank you for consulting our team of subspecialty radiologists. Electronically Signed by: Review of Systems All 13 point review of systems were reviewed with the patient and are negative except as specified in the HPI Physical Exam/Objective Vitals & Measurements most recent past 24 hours Hemodynamics Neurologic Patient Weight Patient Height None Reported Constitutional: No acute distress, well-nourished Eyes: PEERL, EOMI, normal conjunctiva, no scleral icterus ENMT: Moist oral mucosa Neck: Supple, non-tender, intact range of motion Respiratory: Lungs CTAB Cardiovascular: Bradycardic Gastrointestinal: Soft, non-tender, non-distended Musculoskeletal: No joint swelling, no deformity, intact ROM Integumentary: Intact, warm, dry no rashes Neurologic: mild confusion, mild aphasia Psychiatric: Cooperative, appropriate mood and affect Assessment/Plan 1. CVA (cerebrovascular accident) I63.9 Acute left-sided CVA on MRI, neurology was consulted from ER ? We will continue aspirin, started a statin. Try to keep systolic blood pressures less than 200 but can allow permissive hypertension ? Echocardiogram carotid Dopplers ordered for the morning ? PT OT and speech consults ? Bedside swallowing eval for tonight then can start diet -he is not on anticoagulation for a fib due to high risk of bleeding, will discuss with neurology 2. Bradycardia R00.1 We have reduced Coreg dosing with hold orders for heart rate less than 65 patient does have a history of A-fib 3. HTN (hypertension) I10 Holding Lasix at this time, resume Coreg at lower dosin,g continue amlodipine in a.m. Continue Imdur as well 4. UTI (urinary tract infection) N39.0 UA evidence of UTI ? Culture pending ? Continue with cefepime for now as previous micro showed Pseudomonas sensitivity to cefepime 5. A-fib I48.91 Not on anticoagulation due to high risk of bleeding, patient has been compliant with his aspirin at home, I will discuss with neurology tomorrow whether or not they suggest starting anticoagulation ? Continue rate control meds reduced dosage due to current bradycardia 6. BPH with urinary obstruction N40.1 Continue tamsulosin 7. Hypothyroidism E03.9 Continue levothyroxine, check TSH 8. CKD (chronic kidney disease), stage IV N18.4 Noted appears to be at baseline 9. Hypokalemia E87.6 replacement protocol Urinary retention R33.9 Continue tamsulosin ???????Patient is a full code, DVT prophylaxis with Lovenox Ordered: tamsulosin, 0.4 mg, Orally, Capsule, Daily, 07/25/23 9:00:00 Orders: amLODIPine, 10 mg, Orally, Tablet, Daily, 07/25/23 9:00:00 carvedilol, 6.25 mg, Orally, Tablet, BID, 07/25/23 9:00:00 cefePIME, 1 GM, IVPB, Injection, Q12H, Indication: UTI, 07/24/23 18:00:00, Total Volume (mL) = 50 levothyroxine, 25 mCg, Orally, Tablet, Daily, 07/25/23 6:00:00 magnesium sulfate, 4 GM, IVPB, Injection, Q12H, PRN, Lab (Details Required), 07/24/23 17:42:00 potassium chloride, 30 mEq, Orally, Tab, Extended Rel, Unscheduled, PRN, Lab (Details Required), 07/24/23 17:42:00 potassium chloride, 40 mEq, Orally, Tab, Extended Rel, Unscheduled, PRN, Lab (Details Required), 07/24/23 17:42:00 potassium phosphate-sodium phosphate, 1 Packet, Orally, Powder, Unscheduled, PRN, Lab (Details Required), 07/24/23 17:42:00 potassium phosphate-sodium phosphate, 1 Packet, Orally, Powder, Unscheduled, PRN, Lab (Details Required), 07/24/23 17:42:00 Bed Request (Decision to Admit) Collect Specimen Collect Specimen Collect Specimen Echocardiogram with Cardiac Doppler PW/CW/Color Message to Nursing Notify Provider Notify Provider Notify Provider Notify Provider TSH 3rd Gen SerPl QN US Carotid Doppler Bilat Code Status None Recorded Chronic Problem List A-fib BPH with urinary obstruction Bradycardia CKD (chronic kidney disease), stage IV CVA (cerebrovascular accident) Decreased hearing of both ears Diastolic dysfunction Encounter for medication management HTN (hypertension) Hypokalemia Hypothyroidism Ingrown toenail of both feet Pulmonary hypertension Toe pain Urinary retention UTI (urinary tract infection) Procedure/Surgical History ?bil ingrown toenail removal ?left inguinal hernia repair ?left leg/ankle reconstuction Medications Home Medications (7) Active amLODIPine 5 mg oral tablet 10 mg = 2 Tablet, Orally, Daily aspirin 81 mg oral tablet, chewable carvedilol 12.5 mg oral tablet 12.5 mg = 1 Tablet, Orally, BID Flomax 0.4 mg oral capsule 0.4 mg = 1 Capsule, Orally, Daily, Take one pill, 30 minutes after dinner. isosorbide mononitrate 30 mg oral tablet, extended release 30 mg = 1 Tablet, Orally, QAM Lasix 20 mg oral tablet 20 mg = 1 Tablet, Orally, BID levothyroxine 25 mCg (0.025 mg) oral tablet 25 mCg = 1 Tablet, Orally, Daily Active Scheduled Inpatient Medications amLODIPine, Tablet, 10 mg, Orally, Daily, Start: 07/25/23 09:00:00 carvedilol (Coreg), Tablet, 6.25 mg, Orally, BID, Start: 07/25/23 09:00:00 cefePIME, Injection, 1 GM, IVPB, Q12H, Indication: UTI, Start: 07/24/23 18:00:00 levothyroxine, Tablet, 25 mCg, Orally, Daily, Start: 07/25/23 06:00:00 tamsulosin (Flomax), Capsule, 0.4 mg, Orally, Daily, Start: 07/25/23 09:00:00 One-Time Medications Given 07/23/23 00:00:00 TO 07/24/23 17:57:04 None Reported PRN Medications (0600 - 0559) from 07/23 - 07/24 magnesium sulfate, 4 GM, IVPB, Q12H, 0 Dose(s) potassium chloride, 30 mEq, Orally, Unscheduled, 0 Dose(s) potassium chloride, 40 mEq, Orally, Unscheduled, 0 Dose(s) potassium phosphate-sodium phosphate, 250 mg, Orally, Unscheduled, 0 Dose(s) Allergies NKA No Known Medication Allergies Social History Alcohol Past Electronic Cigarette/Vaping E-Cigarette Use Never. Substance Abuse Denies Tobacco Tobacco Use: Never (less than 100 in lifetime). Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 5.5 k/cumm (07/24/23 12:00:00) RBC: 3.94 million/cumm Low (07/24/23 12:00:00) Hgb: 10.6 GM/dL Low (07/24/23 12:00:00) Hct: 33 % Low (07/24/23 12:00:00) MCV: 84 fL (07/24/23 12:00:00) MCH: 27 pg (07/24/23 12:00:00) MCHC: 32.2 GM/dL (07/24/23 12:00:00) RDW: 17.3 % High (07/24/23 12:00:00) Platelet: 162 k/cumm (07/24/23 12:00:00) MPV: 9.5 fL (07/24/23 12:00:00) Neutrophils %: 69 % (07/24/23 12:00:00) Lymphocytes %: 18 % (07/24/23 12:00:00) Monocytes %: 9 % (07/24/23 12:00:00) Eosinophils %: 3 % (07/24/23 12:00:00) Basophils %: 1 % (07/24/23 12:00:00) Absolute Neutrophil: 3.8 k/cumm (07/24/23 12:00:00) Absolute Lymphocyte: 1 k/cumm (07/24/23 12:00:00) Absolute Monocyte: 0.5 k/cumm (07/24/23 12:00:00) Absolute Eosinophil: 0.2 k/cumm (07/24/23 12:00:00) Absolute Basophil: 0 k/cumm (07/24/23 12:00:00) Chemistry: Sodium SerPl QN: 141 mmol/L (07/24/23 12:00:00) Potassium SerPl QN: 3.3 mmol/L Low (07/24/23 12:00:00) Chloride SerPl QN: 108 mmol/L (07/24/23 12:00:00) Carbon Dioxide SerPl QN: 23 mmol/L (07/24/23 12:00:00) Anion Gap: 10 mmol/L (07/24/23 12:00:00) BUN SerPl QN: 48 mg/dL High (07/24/23 12:00:00) Creatinine SerPl QN: 2.87 mg/dL High (07/24/23 12:00:00) Estimated GFR (CKD-EPI, no race): 21 mL/min/1.73m2 Low (07/24/23 12:00:00) Estimated CRCL (CG): 16 mL/min Low (07/24/23 12:00:00) Glucose SerPl QN: 148 mg/dL High (07/24/23 12:00:00) Calcium Total SerPl QN: 8.5 mg/dL (07/24/23 12:00:00) Alkaline Phos SerPl QN: 53 Units/L (07/24/23 12:00:00) ALT SerPl QN: 9 Units/L (07/24/23 12:00:00) AST SerPl QN: 16 Units/L (07/24/23 12:00:00) Bilirubin Total SerPl QN: 1.3 mg/dL High (07/24/23 12:00:00) Total Protein SerPl QN: 6.8 GM/dL (07/24/23 12:00:00) Albumin SerPl QN: 3.9 GM/dL (07/24/23 12:00:00) Magnesium SerPl QN: 2.1 mg/dL (07/24/23 12:00:00) Troponin-I High Sensitivity: 37 ng/L High (07/24/23 12:56:00) Lactate Venous Pl QN: 1.3 mmol/L (07/24/23 14:55:00) Coagulation: PT: 15.2 seconds High (07/24/23 12:00:00) INR: 1.32 High (07/24/23 12:00:00) aPTT: 34.5 seconds (07/24/23 12:00:00) Urine Studies: Color: Yellow (07/24/23 15:18:00) Clarity: Slightly Cloudy (07/24/23 15:18:00) Specific Gravity: 1.014 (07/24/23 15:18:00) pH: 6.5 (07/24/23 15:18:00) Protein: 70 Abnormal (07/24/23 15:18:00) Glucose: Normal (07/24/23 15:18:00) Ketones: NEGATIVE (07/24/23 15:18:00) Bilirubin: NEGATIVE (07/24/23 15:18:00) Hgb Ur: Small 1+ Abnormal (07/24/23 15:18:00) Nitrite: Positive 2+ Abnormal (07/24/23 15:18:00) Urobilinogen: Normal (07/24/23 15:18:00) Leukocyte Esterase Ur: Large500 Abnormal (07/24/23 15:18:00) WBC: 51-100 Abnormal (07/24/23 15:18:00) RBC: 3-5 Abnormal (07/24/23 15:18:00) Bacteria: Few Abnormal (07/24/23 15:18:00) Squamous Epithelial: Few (07/24/23 15:18:00) All Other Labs: COVID 19 Specimen Source: Nasal (07/24/23 16:15:00) Coronavirus SARS-CoV2 Rapid: Not Detected (07/24/23 16:15:00) Diagnostics Radiology Results - Last 24 hours Across Visits 07/24/2023 12:42 - XR Chest PA or AP Portable IMPRESSION:1. No acute findings in the chest.Thank you for consulting our team of subspecialty radiologists. 07/24/2023 14:43 - MRI Brain W/O IV Contrast IMPRESSION: 1. Acute left MCA territory infarct involving predominantly thecortex of the inferior division without associated hemorrhage orsignificant mass effect.2. Old left parieto-occipital infarct.3. Technically degraded MRA, limiting evaluation.4. Lack of flow-related signal in the left PCA, which may reflectchronic occlusion.5. Suspected high-grade stenosis of the right P1-P2 junction.6. Likely moderate stenoses of the left M1 segment.7. Slight prominence of the basilar tip, nonspecific but possiblyrepresenting an aneurysm.8. Further characterization of the above findings with CTA of thehead is advised.Findings to be communicated to the ordering provider by clerical.Thank you for consulting our team of subspecialty radiologists. 07/24/2023 14:44 - MRA Brain W/O IV Contrast IMPRESSION: 1. Acute left MCA territory infarct involving predominantly thecortex of the inferior division without associated hemorrhage orsignificant mass effect.2. Old left parieto-occipital infarct.3. Technically degraded MRA, limiting evaluation.4. Lack of flow-related signal in the left PCA, which may reflectchronic occlusion.5. Suspected high-grade stenosis of the right P1-P2 junction.6. Likely moderate stenoses of the left M1 segment.7. Slight prominence of the basilar tip, nonspecific but possiblyrepresenting an aneurysm.8. Further characterization of the above findings with CTA of thehead is advised.Findings to be communicated to the ordering provider by clerical.Thank you for consulting our team of subspecialty radiologists. 07/24/2023 14:52 - CT Head W/o IV Contrast IMPRESSION: 1. The acute left MCA territory infarct is better depicted on MRI.2. No acute intracranial hemorrhage or significant mass effect.Thank you for consulting our team of subspecialty radiologists. Signature Line Electronically Signed on 07/24/23 17:57 ________________________________________________________ ________________________________________________________

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2689437

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

schwer
Staat
MN
Alter
13,0
Geschlecht
M
Eingang
02.10.2023
Impfdatum
02.10.2023
Beginn
02.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Anxiety Dizziness Feeling hot Loss of consciousness Syncope

Symptomtext

A few minutes after providing vaccination, client reported feeling warm and appeared anxious. Client was offered water and fruit snacks to help with potential nausea. Client then fainted for a short period of time. Client regained consciousness and was alert and oriented x3. Client drank more water until dizziness subsided, and Mom and client remained under observation until client stated he was feeling better and able to stand up without any dizziness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2646343

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

schwer
Staat
MN
Alter
11,0
Geschlecht
F
Eingang
16.06.2023
Impfdatum
16.06.2023
Beginn
16.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fall Nausea Syncope

Symptomtext

Patient received 3 vaccines. 5-7 minutes later, she had a vasovagal syncopal episode. She started feeling nauseous, sat down, and fell against her mother's shoulder. Patient was given juice and a snack and recovered quickly. 5 minutes later, her symptoms resolved completely.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2707314

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

moderat
Staat
NE
Alter
37,0
Geschlecht
M
Eingang
31.10.2023
Impfdatum
17.10.2023
Beginn
17.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Injected limb mobility decreased Limb discomfort Muscular weakness Pain

Symptomtext

Situation: * Left, shoulder pain, limited range of motion and weakness subsequent to receiving Tdap Vaccine on 10/17/2023. Background: * Employee scheduled for clinic visit on 10/17/2023 @ 1230 to receive Tdap vaccination and MMR#2 vaccination. * Employee presented and VIS for Tdap & MMR, consented to receiving both vaccinations, completed the allergy screening questionnaire. * Refer to immunization tab for details of each vaccine. * Employee attempted to contact Employee Health on 10/26/2023 by email stating, "H, Last Tuesday I received a shot in my left arm. I've had some discomfort and limited mobility since then. Do I need to get this looked at?" * 10/30/2023: Employee presented to Employee Health office for assessment. * Initial assessment: He reported receiving a Tdap vaccine two weeks ago, sending an email last week. He reported, "sharp pain, left shoulder area, rating 7-8/10 that occurs in an instant and then gone, or, some days a dull ache all day'. * Left shoulder pain is reported when lifts his left arm forward or sideways at shoulder height. * Reported no swelling or redness at site. * Denied other types of strain, such as lifting, to cause left shoulder pain. * Reported, using heat, Ibuprofen 800 mg once every other day". Assessment: * 1245: Employee contacted and presented to Employee Health for assessment. * acknowledges receiving his email on 10/26/2023. * Employee stated, "my left arm was sore the day of the shot describing the pain as constant and uncomfortable for a few days, thinking it would get better and go away". * He reported weakness and pain when extending his left upper extremity forward to shoulder height. * He also reports weakness and pain when attempting to use his left arm to apply deodorant to the right axilla/under arm area. * Bilateral finger/hand grip is equal but left-hand grip weak when said nurse pulled away with employee letting go of said nurses' fingers. * Reports discomfort to left, deltoid area when he presses this area with fingers of right hand. * Denies changes in sensation. Plan: * Reviewed reporting process; completing forms to be sent to Case Management Team. * Reviewed Case Management Packet, acknowledging understanding of packet contents. * Emphasized to accept phone call from Case Management Team explaining they will further assess the injury. * Submit VAERS report. _________________________________________________________________________

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
None at this time.
Aktuelle Erkrankungen
None Known
Vorgeschichte
None Known
Andere Medikamente
None known
Allergien
None Known
Vorherige Impfungen
-

VAERS 2634854

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

moderat
Staat
MA
Alter
20,0
Geschlecht
M
Eingang
22.05.2023
Impfdatum
21.05.2023
Beginn
21.05.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Disorientation Dizziness Immediate post-injection reaction Paraesthesia

Symptomtext

After receiving Adacel vaccine, patient felt immediately lightheaded. He sat down and was very woozy and disoriented for a minute. He reported continued lightheadedness and some tingling in his arms and hands. After about a minute, the patient began to progressively feel better. He drank some water and sat for about 10 more minutes, then said he was feeling totally back to normal and got up and left. He declined any sort of follow-up care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2633560

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

moderat
Staat
NV
Alter
31,0
Geschlecht
F
Eingang
18.05.2023
Impfdatum
09.05.2023
Beginn
16.05.2023
Tage bis Beginn
7,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Paraesthesia

Symptomtext

Patient called with c/o tingling sensation above right AC area. Denies any associated pain, swelling, fever, SOB, itching. Tingling started about 1 wk post administration of vaccines. Advised to f/u with PCP with any worsening or non-resolution of tingling within the next few days. Advised to apply warm compresses to the area as needed and avoid cold compresses.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
Tri-Ortho BCP
Allergien
None reported
Vorherige Impfungen
-

VAERS 2628570

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

moderat
Staat
AR
Alter
58,0
Geschlecht
F
Eingang
08.05.2023
Impfdatum
02.05.2023
Beginn
03.05.2023
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Breast swelling Headache Injection site bruising Lymphadenopathy Pain Peripheral swelling Pyrexia Tremor

Symptomtext

Bruising above the injection site; swelling all the way down the arm, into the lymph nodes, and breast; soreness, shakes, aches, low grade fever, headache

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Linzess, Mounjaro, Lisinopril, Sulfasalazine, Estradiol, Duloxetine, Pantoprazole
Allergien
-
Vorherige Impfungen
-

VAERS 2688333

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

mild
Staat
OR
Alter
34,0
Geschlecht
F
Eingang
28.09.2023
Impfdatum
08.09.2023
Beginn
10.09.2023
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site pruritus Injection site vesicles

Symptomtext

Employee noticed local itching and some redness and developed a small clear fluid blister with a few smaller raised blisters in area. Determined was around the Heplisav B site. Had used three different bandaids to differentiate which one was which. Applied coolness to site and told to not scratch/open blister.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2655441

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

mild
Staat
CA
Alter
43,0
Geschlecht
M
Eingang
12.07.2023
Impfdatum
06.07.2023
Beginn
07.07.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site swelling Pyrexia

Symptomtext

Fever of 101 F on 7/7/23 and 7/8/23. Resolved 7/9 Redness and swelling on L deltoid about 10 cm x 5 cm around injection sight - no pus or discharge All resolved on own

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
fatigue and soreness common after all vaccines for pt

VAERS 2649374

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

mild
Staat
CA
Alter
52,0
Geschlecht
M
Eingang
26.06.2023
Impfdatum
19.06.2023
Beginn
19.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Injection site erythema Injection site swelling Injection site warmth

Symptomtext

Patient came into clinic for Triage 6/26/2023 due to possible allergic reaction for vaccine TDap given 06/19/2023. Nurse observed site. Site was red, swollen and warm to touch. Nurse notified provider, visit was then escalated to a provider visit.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
MEDICAL HX: None
Vorgeschichte
MEDICAL HX: None
Andere Medikamente
fluticasone (Flonase) 50 mcg/actuation nasal spray diclofenac (Voltaren) 1 % topical gel gabapentin (Neurontin) 600 mg tablet meloxicam (Mobic) 7.5 mg tablet
Allergien
No Known Allergies
Vorherige Impfungen
-

VAERS 2620929

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

mild
Staat
FL
Alter
48,0
Geschlecht
M
Eingang
25.04.2023
Impfdatum
25.04.2023
Beginn
25.04.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness

Symptomtext

PATIENT GOT DIZZY AND PUT HEAD DOWN. HE THEN QUICKLY RECOVERED AND WAS FINE. WE MONITERED PATIENT FOR 30 MINUTES AFTER AND HE WAS OK. HIS FRIEND DROVE HIM HOME.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NONE
Vorherige Impfungen
-

VAERS 2619611

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

mild
Staat
MI
Alter
49,0
Geschlecht
F
Eingang
24.04.2023
Impfdatum
14.04.2023
Beginn
21.04.2023
Tage bis Beginn
7,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Injection site pruritus Lymphadenopathy

Symptomtext

Received vaccine on 4/14/23 and noticed redness in upper arm on 4/21/23. Redness increasing throughout the day. Injection site itchy. Swollen lymph nodes under left arm since 4/19/23.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pruritus
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Chrohns Disease Diabetes
Andere Medikamente
Metformin, Norethindrone Acetate, Omeprazole and Wegovy
Allergien
None
Vorherige Impfungen
-

VAERS 2726870

SANOFI PASTEUR · TDAP (ADACEL) · Charge u7666aa

gering
Staat
FL
Alter
65,0
Geschlecht
F
Eingang
22.12.2023
Impfdatum
07.11.2023
Beginn
07.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Gastrointestinal disorder Muscle spasms

Symptomtext

reported on 12/22/2023 that client had started back on 11/07/2023 with charley horses cramps in legs, she has had them for the past 6 weeks. she has not been seen by a physician she "doesn't have one and hasn't needed one" She also c/o Gi issues unknown how long symptoms have been going on.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Gastrointestinal disorder
Hospital-Tage
-
Labordaten
none to my knowledge
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
UNKNOWN
Allergien
-
Vorherige Impfungen
-

VAERS 2709454

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

gering
Staat
WI
Alter
11,0
Geschlecht
M
Eingang
03.11.2023
Impfdatum
11.07.2023
Beginn
11.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Hypoaesthesia Tinnitus

Symptomtext

Patient received Tdap, Meningococcal Conjugate Quadrivalent (Left Deltoid) and HPV (Right Deltoid) vaccines today during well visit. Upon completion of vaccines, after leaving room and walking to check out, patient stated to parent that he could not feel his hands and heard "noises". Parent escorted patient to a seated position in chair while Patient Service Specialist notified Registered Nurses. RNs immediately responded. Patient instructed to lay down on parent, was pale at this time. Patient provided with apple juice, ice water and a cool wash cloth for forehead. Patient's skin color began to return and stated that he could feel his arms again after resting and having some juice. Stated that he no longer was hearing noises. Patient was then instructed to sit up into a seated position to see how he tolerated. Reported that he felt better. After approximately 5 minutes, was instructed to stand. Upon standing reported that he felt fine. Patient then remained seated in lobby for an additional 10 minutes prior to leaving. Reported at check out while stating that he was better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypoaesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2682071

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

gering
Staat
CA
Alter
43,0
Geschlecht
F
Eingang
14.09.2023
Impfdatum
09.09.2023
Beginn
09.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dysphagia Oropharyngeal discomfort

Symptomtext

10 mins after vaccine given patient complained of "thick throat" difficulty swallowing. No other symptoms noted

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dysphagia
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
Allergy seasonal and asthma
Andere Medikamente
OTC Allergy Meds
Allergien
Covid 19 vaccine in past
Vorherige Impfungen
Covid 19 vaccine initial dose

VAERS 2656658

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

gering
Staat
CO
Alter
12,0
Geschlecht
F
Eingang
14.07.2023
Impfdatum
06.07.2023
Beginn
06.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Patient received a dose of Boostrix on 7/14/2022 and then a dose of Adacel on 7/6/2023, less than a year later. The provider ordered an HPV vaccine and the Tdap was given in error. There were no adverse symptoms reported by patient or parent

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2655222

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7666AA

gering
Staat
CO
Alter
12,0
Geschlecht
F
Eingang
11.07.2023
Impfdatum
06.07.2023
Beginn
06.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration Medication error No adverse event

Symptomtext

administration of tdap doses with the interval of less than a year with no reported adverse event; Initial information received on 07-Jul-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 12 years old female patient who was administered diphtheria-2/tetanus/5 AC pertussis vaccine [Adacel] dose with the interval of less than a year with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 06-Jul-2023, the patient received 0.5 mL dose 2 of suspect diphtheria-2/tetanus/5 AC pertussis vaccine, suspension for injection (batch number: U7666AA; expiry date: 08-Mar-2025) via intramuscular route in the right deltoid for immunization with the interval of less than a year with no reported adverse event (inappropriate schedule of product administration) (same day latency). It was reported that, Adacel was given to patient that had Tdap 11 years and 9 months before that, getting a repeat dose a year later. They want to know what are the ramifications for the patient. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event administration of tdap doses with the interval of less than a year with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2023SA210162:01683487

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-